Omaxe Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
OMAXE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 3.4 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Omaxe Limited reported audited financial results for FY2025-26 ending March 31, 2026. Standalone revenue grew 16% to Rs. 453.64 Crores from Rs. 389.85 Crores, but consolidated revenue declined 20% to Rs. 1,253.40 Crores from Rs. 1,560.99 Crores. The company continues to report significant losses with standalone net loss of Rs. 195.61 Crores and consolidated net loss of Rs. 696.80 Crores. Auditors issued an unmodified (clean) opinion, but drew attention to an Emphasis of Matter regarding a SEBI order dated July 30, 2024 under Section 11, 11B of the SEBI Act, for which the company has filed an appeal with SAT (next hearing July 7, 2026). The company also changed its internal auditor from Doogar & Associates to M/s Aditya Agarwal & Company due to the former's resignation.
The stock may face pressure due to ongoing losses on both standalone and consolidated basis, declining consolidated revenue, and the unresolved SEBI regulatory matter despite clean audit opinion. The large subsidiary structure (144+ group companies) with significant consolidated losses warrants caution.